DrugPatentWatch Database Preview
FML-S Drug Profile
» See Plans and Pricing
Which patents cover Fml-s, and what generic alternatives are available?
Fml-s is a drug marketed by Allergan and is included in one NDA.
The generic ingredient in FML-S is fluorometholone; sulfacetamide sodium. There are five drug master file entries for this compound. Additional details are available on the fluorometholone; sulfacetamide sodium profile page.
Summary for FML-S
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Bulk Api Vendors: | 99 |
| Patent Applications: | 3,972 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | FML-S at DailyMed |
US Patents and Regulatory Information for FML-S
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Allergan | FML-S | fluorometholone; sulfacetamide sodium | SUSPENSION/DROPS;OPHTHALMIC | 019525-001 | Sep 29, 1989 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
